Publication | Closed Access

Injectable polypeptide hydrogel for dual-delivery of antigen and TLR3 agonist to modulate dendritic cells in vivo and enhance potent cytotoxic T-lymphocyte response against melanoma

Cancer ImmunosurveillanceEngineeringInjectable Polypeptide HydrogelImmunoengineeringImmunologyTherapeutic VaccineImmunomodulationBiomedical EngineeringDendritic Cell BiologyImmunotherapyMedicineDendritic Cells